FGL2 and cystic fibrosis: Overall, however, FGL2’s reported role in fibrosis and its growing interest as a therapeutic target in treating autoimmune disorders and transplant rejection make it one of the more interesting novel interactors of CFTR uncovered in this study and additional research to determine its potential for use as a therapeutic target in CF seems warranted.